Skip to main content
Premium Trial:

Request an Annual Quote

Exact Laboratories Gets US Patent for Genome Tech

Premium

MAYNARD, Mass.--Exact Laboratories here has received a US patent for methods for analyzing genetic variations, such as single nucleotide polymorphisms, for pharmaco-genomics and genetics research. The technology also allows many patient samples to be pooled for a single analysis.

Filed under

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.